Mimo Biosciences
Sanitas, Gutinver and private investor
Other
Biotechnology
Mimo Biosciences / Sanitas
CREA Inversión advised Mimo Biosciences in the capital increase of Sanitas, Gutinver and private investor.
Mimo Bioscience is a spin-off of the Cima University of Navarra that specialises in preclinical research services in the field of onco-hematology.
Sanitas is a leading health insurance provider in Spain, offering a wide range of services to ensure comprehensive healthcare coverage.
The transaction was led by Ignacio Olábarri, Managing Partner.
More deals available on the company's website.
Contact Person
Some other Transactions by the Firm
Interested in becoming a member of GCG?
If you are an international M&A advisory firm and you are regarded as one of the leading firms in your profession in your country, consistently providing excellent client services and meeting high quality standards, you meet the basic requirements for a GCG membership.